Related Experiment Video
Updated: Mar 18, 2026
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit
Patrick A Tully1, Andrew J Gogos, Craig Love
1*Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia;‡The University of Notre Dame Australia, School of Medicine, Melbourne Clinical School, Werribee, Victoria;§The Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
Reoperation for recurrent glioblastoma may improve survival, but this benefit is linked to favorable patient characteristics, not the reoperation itself. Further research with larger patient cohorts is recommended.
Area of Science:
- Neuro-oncology
- Surgical oncology
- Clinical outcomes research
Background:
- Glioblastoma is an aggressive primary brain tumor with inevitable recurrence.
- Current treatment strategies lack clear guidelines for recurrent glioblastoma management.
- Identifying predictors of reoperation and prognostic survival variables is crucial.
Purpose of the Study:
- To identify surgical factors predicting reoperation for recurrent glioblastoma.
- To determine prognostic variables associated with survival, including reoperation.
- To evaluate the impact of reoperation on overall survival.
Main Methods:
- Retrospective cohort study of adult glioblastoma patients (2010-2013).
- Comparison of reoperation vs. nonreoperation groups using t-tests and Fisher exact tests.
- Univariable and Cox regression multivariable analyses were performed.
Main Results:
- 24% of 204 patients underwent reoperation for recurrence.
- Reoperation was initially associated with longer overall survival (20.1 vs. 9.0 months).
- Subgroup analysis indicated reoperation is not an independent predictor of survival, suggesting selection bias.
Conclusions:
- Patients selected for reoperation possess favorable prognostic traits.
- The observed survival advantage in reoperation patients is likely due to these characteristics.
- A large clinical registry is recommended for standardized data collection in recurrent glioblastoma.
